BCL7C antibody (PE)
Quick Overview for BCL7C antibody (PE) (ABIN2170565)
Target
See all BCL7C AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BCL7C
-
Isotype
- IgG
-
-
-
-
Application Notes
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
-
- BCL7C (B-Cell CLL/lymphoma 7C (BCL7C))
-
Alternative Name
- BCL7C
-
Background
-
Synonyms: B cell CLL/lymphoma 7 protein family member C, B cell CLL/lymphoma 7C, B-cell CLL/lymphoma 7 protein family member C, BCL 7C, Bcl7c, BCL7C_HUMAN.
Background: May play an anti-apoptotic role.
-
Gene ID
- 9274
Target
-